Document is current
Any future updates will be listed below
-
Authors
Wang, Tengfei
Li, Rumeng
Liu, Shuyan
Wu, Qiuji
Ouyang, Wen
Xie, Conghua
-
Funding
Funding for this research was provided by:
Health Commission of Hubei Province scientific research project (WJ2021M171)
Chen Xiao-ping Foundation for the development of science and technology of Hubei province (CXPJJH124001-2420)
Beijing Bethune Charitable Foundation (2023-YJ-152-J-008)
National Natural Science Foundation of China (81972852)
Key Research & Development Project of Hubei Province (2020BCA069)
Health Commission of Hubei Province Medical Leading Talent Project, and Chinese Society of Clinical Oncology TopAlliance Tumor Immune Research Fund (Y-JS2019-036)
- License Information
-
More Information
Article History
Received: 26 January 2024
Accepted: 25 October 2024
First Online: 31 October 2024
Declarations
:
: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This retrospective study was approved by the Ethics Committee of Zhongnan Hospital of Wuhan University. The Ethics Committee approved oral informed consent, as the data were reviewed and analyzed anonymously. Informed consent was obtained orally from the included patients by telephone. All the methods included in this study are in accordance with the declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
